Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

agilon health Inc (AGL)

NYSE
Currency in USD
2.37
+0.28(+13.16%)
Real-time Data
AGL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.112.39
52 wk Range
1.5013.76
Key Statistics
Edit
Prev. Close
2.09
Open
2.11
Day's Range
2.11-2.39
52 wk Range
1.5-13.76
Volume
2.91M
Average Vol. (3m)
4.71M
1-Year Change
-81.47%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGL Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.63
Upside
+55.79%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

agilon health Inc Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

agilon health Inc SWOT Analysis


Future Trajectory
Analyst targets range from $2 to $8, reflecting varied opinions on Agilon's ability to overcome challenges and capitalize on the expanding value-based care market.
Market Dynamics
Delve into Agilon's position in the competitive value-based care sector, balancing strong membership growth against the need for improved financial performance.
Financial Crossroads
Explore Agilon's mixed Q3 results, featuring revenue growth but significant EBITDA losses, and the company's strategic response to improve profitability.
Value-Based Hurdles
Agilon Health grapples with rising medical costs and operational challenges in its pursuit of growth in the Medicare Advantage market through physician partnerships.
Read full SWOT analysis
AGL Full Pro Research
Institutional-Grade Stock Analysis
Understand how AGL earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

agilon health Inc Earnings Call Summary for Q4/2024

  • Medicare Advantage membership grew 37% YoY to 525,000; total revenue up 28% to $1.45B, but medical margin loss of $58M reported
  • Full-year membership guidance raised to 527,000; revenue guidance increased to $6.057B; medical margin guidance lowered to $225M for 2024
  • Plans to exit unprofitable partnerships and ~10% of payer contracts, potentially reducing future membership and revenue
  • Projected 452,000-482,000 Medicare Advantage members for 2025, plus 45,000 from new class; $325M medical margin foundation expected
  • $100M revenue gap identified due to lower adoption/capture rates; cash burn projected at $110M for next year
Last Updated: 11/10/2024, 11:02 AM
Read Full Transcript

Compare AGL to Peers and Sector

Metrics to compare
AGL
Peers
Sector
Relationship
P/E Ratio
−2.8x−1.1x−0.7x
PEG Ratio
0.01−0.060.00
Price / Book
1.5x0.7x2.6x
Price / LTM Sales
0.2x0.7x3.2x
Upside (Analyst Target)
19.6%36.7%44.5%
Fair Value Upside
Unlock26.6%6.6%Unlock

Analysts' Recommendations

3 Buy
14 Hold
3 Sell
Ratings:
15 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 3.63

(+53.02% Upside)

People Also Watch

49.90
BHE
+2.90%
48.98
EPAC
+1.49%
27.05
ARIS
+0.56%
9.36
MG
+0.54%
84.05
PRIM
+0.41%

FAQ

What Is the agilon health (AGL) Stock Price Today?

The agilon health stock price today is 2.37

What Stock Exchange Does agilon health Trade On?

agilon health is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for agilon health?

The stock symbol for agilon health is "AGL."

What Is the agilon health Market Cap?

As of today, agilon health market cap is 943.52M.

What is agilon health Earnings Per Share?

The agilon health EPS is -0.944.

What Is the Next agilon health Earnings Date?

agilon health will release its next earnings report on Feb 26, 2025.

From a Technical Analysis Perspective, Is AGL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.